glp 1 analog Science Behind GIP and Glucagon Receptor Agonists for Obesity Research | News & Announcements The Generation and Function of
Description
It is taken once a week through a subcutaneous injection (under the skin) using a pre-filled injector pen
adults have obesity, with the rate increasing more than 10 percentage points in the past 2 decades
Incretin mimetics considerably expanded their proven benefits beyond obesity in 2024
Personalized medical support can prevent or mitigate these symptoms, improving adherence and the overall success of the therapy
Our blog series on GLP-1 agonists for weight loss is aimed at unpacking the science behind this new frontier in weight management, presenting a detailed overview of how they work, their efficacy, and their role in a holistic approach to health and wellness.
